Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 496

1.

Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).

Hall DA, Robertson EE, Leehey M, McAsey A, Ouyang B, Berry-Kravis E, O'Keefe JA.

PLoS One. 2020 Feb 13;15(2):e0225191. doi: 10.1371/journal.pone.0225191. eCollection 2020.

2.

Evaluation of a Cognitive Behavioral Model of Tinnitus Distress: A Cross-Sectional Study Using Structural Equation Modeling.

Handscomb L, Shorter GW, Hoare DJ, Hall DA.

Ear Hear. 2019 Dec 31. doi: 10.1097/AUD.0000000000000826. [Epub ahead of print]

PMID:
32032227
3.

Defining Symptom Concepts in Chronic Subjective Tinnitus: Web-Based Discussion Forum Study.

Hibbert A, Vesala M, Kerr M, Fackrell K, Harrison S, Smith H, Hall DA.

Interact J Med Res. 2020 Jan 7;9(1):e14446. doi: 10.2196/14446.

4.

A CMOS Magnetoresistive Sensor Front-End With Mismatch-Tolerance and Sub-ppm Sensitivity for Magnetic Immunoassays.

Zhou X, Sveiven M, Hall DA.

IEEE Trans Biomed Circuits Syst. 2019 Dec;13(6):1254-1263. doi: 10.1109/TBCAS.2019.2949725. Epub 2019 Oct 25.

PMID:
31670677
5.

The association between subcortical and cortical fMRI and lifetime noise exposure in listeners with normal hearing thresholds.

Dewey RS, Francis ST, Guest H, Prendergast G, Millman RE, Plack CJ, Hall DA.

Neuroimage. 2020 Jan 1;204:116239. doi: 10.1016/j.neuroimage.2019.116239. Epub 2019 Oct 3.

6.

Noninvasive Bimodal Neuromodulation for the Treatment of Tinnitus: Protocol for a Second Large-Scale Double-Blind Randomized Clinical Trial to Optimize Stimulation Parameters.

Conlon B, Hamilton C, Hughes S, Meade E, Hall DA, Vanneste S, Langguth B, Lim HH.

JMIR Res Protoc. 2019 Sep 27;8(9):e13176. doi: 10.2196/13176.

7.

Impact of Temporomandibular Joint Complaints on Tinnitus-Related Distress.

Edvall NK, Gunan E, Genitsaridi E, Lazar A, Mehraei G, Billing M, Tullberg M, Bulla J, Whitton J, Canlon B, Hall DA, Cederroth CR.

Front Neurosci. 2019 Aug 22;13:879. doi: 10.3389/fnins.2019.00879. eCollection 2019.

8.

Editorial: Bridging the gap between animal and human studies of hearing.

Hall DA, Plack CJ.

Hear Res. 2019 Oct;382:107778. doi: 10.1016/j.heares.2019.107778. Epub 2019 Aug 7. No abstract available.

PMID:
31470340
9.

RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.

Dutta D, Kundu M, Mondal S, Roy A, Ruehl S, Hall DA, Pahan K.

Neurobiol Dis. 2019 Dec;132:104575. doi: 10.1016/j.nbd.2019.104575. Epub 2019 Aug 22. Review.

10.

Hypertension and progressive supranuclear palsy.

Rabadia SV, Litvan I, Juncos J, Bordelon Y, Riley DE, Standaert D, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J; ENGENE PSP study.

Parkinsonism Relat Disord. 2019 Sep;66:166-170. doi: 10.1016/j.parkreldis.2019.07.036. Epub 2019 Aug 3.

PMID:
31420308
11.

Patient Knowledge and Attitudes towards Genetic Testing in Parkinson's Disease Subjects with Deep Brain Stimulation.

Fraint A, Ouyang B, Metman LV, Jones C, Hall DA, Marder K, Pal G.

Parkinsons Dis. 2019 Apr 21;2019:3494609. doi: 10.1155/2019/3494609. eCollection 2019.

12.

Editorial: Towards an Understanding of Tinnitus Heterogeneity.

Cederroth CR, Gallus S, Hall DA, Kleinjung T, Langguth B, Maruotti A, Meyer M, Norena A, Probst T, Pryss R, Searchfield G, Shekhawat G, Spiliopoulou M, Vanneste S, Schlee W.

Front Aging Neurosci. 2019 Mar 19;11:53. doi: 10.3389/fnagi.2019.00053. eCollection 2019. No abstract available.

13.

A balanced randomised placebo controlled blinded phase IIa multi-centre study to investigate the efficacy and safety of AUT00063 versus placebo in subjective tinnitus: The QUIET-1 trial.

Hall DA, Ray J, Watson J, Sharman A, Hutchison J, Harris P, Daniel M, Millar B, Large CH.

Hear Res. 2019 Jun;377:153-166. doi: 10.1016/j.heares.2019.03.018. Epub 2019 Mar 27.

14.

Betahistine for tinnitus.

Wegner I, Hall DA, Smit AL, McFerran D, Stegeman I.

Cochrane Database Syst Rev. 2018 Dec 28;12:CD013093. doi: 10.1002/14651858.CD013093.pub2. [Epub ahead of print] Review.

15.

Standardised profiling for tinnitus research: The European School for Interdisciplinary Tinnitus Research Screening Questionnaire (ESIT-SQ).

Genitsaridi E, Partyka M, Gallus S, Lopez-Escamez JA, Schecklmann M, Mielczarek M, Trpchevska N, Santacruz JL, Schoisswohl S, Riha C, Lourenco M, Biswas R, Liyanage N, Cederroth CR, Perez-Carpena P, Devos J, Fuller T, Edvall NK, Hellberg MP, D'Antonio A, Gerevini S, Sereda M, Rein A, Kypraios T, Hoare DJ, Londero A, Pryss R, Schlee W, Hall DA.

Hear Res. 2019 Jun;377:353-359. doi: 10.1016/j.heares.2019.02.017. Epub 2019 Mar 2.

16.

How Do We Know That Our Patients Have Benefitted From Our ENT/Audiological Interventions? Presented at the Annual Meeting of ADANO 2016 in Berlin.

Hall DA, Kitterick P, Heffernan E, Fackrell K, Lucas L, Ferguson M.

Otol Neurotol. 2019 Apr;40(4):e474-e481. doi: 10.1097/MAO.0000000000001937.

PMID:
30870383
17.

Standardized questions in English for estimating tinnitus prevalence and severity, hearing difficulty and usage of healthcare resources, and their translation into 11 European languages.

Biswas R, Lugo A, Gallus S, Akeroyd MA, Hall DA.

Hear Res. 2019 Jun;377:330-338. doi: 10.1016/j.heares.2019.02.008. Epub 2019 Feb 22.

PMID:
30853349
18.

Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale.

Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, Zhang L, Leehey MA.

Mov Disord Clin Pract. 2019 Jan 22;6(2):120-124. doi: 10.1002/mdc3.12708. eCollection 2019 Feb.

19.

One Size Does Not Fit All: Developing Common Standards for Outcomes in Early-Phase Clinical Trials of Sound-, Psychology-, and Pharmacology-Based Interventions for Chronic Subjective Tinnitus in Adults.

Hall DA, Hibbert A, Smith H, Haider HF, Londero A, Mazurek B, Fackrell K; Core Outcome Measures in Tinnitus (COMiT) initiative.

Trends Hear. 2019 Jan-Dec;23:2331216518824827. doi: 10.1177/2331216518824827.

20.

Can Adding Constitutive Receptor Activity Redefine Biased Signaling Quantification?

Zhou B, Hall DA, Giraldo J.

Trends Pharmacol Sci. 2019 Mar;40(3):156-160. doi: 10.1016/j.tips.2019.01.002. Epub 2019 Feb 1. Review.

PMID:
30718029
21.

Gap-induced inhibition of the post-auricular muscle response in humans and guinea pigs.

Wilson CA, Berger JI, de Boer J, Sereda M, Palmer AR, Hall DA, Wallace MN.

Hear Res. 2019 Mar 15;374:13-23. doi: 10.1016/j.heares.2019.01.009. Epub 2019 Jan 17.

22.

Association Between Residual Inhibition and Neural Activity in Patients with Tinnitus: Protocol for a Controlled Within- and Between-Subject Comparison Study.

Hu S, Anschuetz L, Huth ME, Sznitman R, Blaser D, Kompis M, Hall DA, Caversaccio M, Wimmer W.

JMIR Res Protoc. 2019 Jan 9;8(1):e12270. doi: 10.2196/12270.

23.

Sound therapy (using amplification devices and/or sound generators) for tinnitus.

Sereda M, Xia J, El Refaie A, Hall DA, Hoare DJ.

Cochrane Database Syst Rev. 2018 Dec 27;12:CD013094. doi: 10.1002/14651858.CD013094.pub2.

24.

High-Density Redox Amplified Coulostatic Discharge-Based Biosensor Array.

Sun AC, Alvarez-Fontecilla E, Venkatesh AG, Aronoff-Spencer E, Hall DA.

IEEE J Solid-State Circuits. 2018 Jul;53(7):2054-2064. doi: 10.1109/JSSC.2018.2820705. Epub 2018 Apr 27.

25.

Pathophysiology of Subjective Tinnitus: Triggers and Maintenance.

Haider HF, Bojić T, Ribeiro SF, Paço J, Hall DA, Szczepek AJ.

Front Neurosci. 2018 Nov 27;12:866. doi: 10.3389/fnins.2018.00866. eCollection 2018. Review.

26.

The COMiT'ID Study: Developing Core Outcome Domains Sets for Clinical Trials of Sound-, Psychology-, and Pharmacology-Based Interventions for Chronic Subjective Tinnitus in Adults.

Hall DA, Smith H, Hibbert A, Colley V, Haider HF, Horobin A, Londero A, Mazurek B, Thacker B, Fackrell K; Core Outcome Measures in Tinnitus (COMiT) initiative.

Trends Hear. 2018 Jan-Dec;22:2331216518814384. doi: 10.1177/2331216518814384.

27.

Author response: The state of clinical research in neurology.

Hall DA.

Neurology. 2018 Nov 20;91(21):984. doi: 10.1212/WNL.0000000000006542. No abstract available.

PMID:
30455257
28.

Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial.

Hall DA, Moore C, Comella C; SPARX Study Group.

Trials. 2018 Nov 14;19(1):630. doi: 10.1186/s13063-018-2958-z.

29.

Magnetoresistive biosensors with on-chip pulsed excitation and magnetic correlated double sampling.

Kim K, Hall DA, Yao C, Lee JR, Ooi CC, Bechstein DJB, Guo Y, Wang SX.

Sci Rep. 2018 Nov 7;8(1):16493. doi: 10.1038/s41598-018-34720-0.

30.

Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review.

Prayuenyong P, Taylor JA, Pearson SE, Gomez R, Patel PM, Hall DA, Kasbekar AV, Baguley DM.

Front Oncol. 2018 Sep 25;8:363. doi: 10.3389/fonc.2018.00363. eCollection 2018.

31.

The Noise Exposure Structured Interview (NESI): An Instrument for the Comprehensive Estimation of Lifetime Noise Exposure.

Guest H, Dewey RS, Plack CJ, Couth S, Prendergast G, Bakay W, Hall DA.

Trends Hear. 2018 Jan-Dec;22:2331216518803213. doi: 10.1177/2331216518803213. Review.

32.

Cognitive function impacts gait, functional mobility and falls in fragile X-associated tremor/ataxia syndrome.

O'Keefe JA, Robertson EE, Ouyang B, Carns D, McAsey A, Liu Y, Swanson M, Bernard B, Berry-Kravis E, Hall DA.

Gait Posture. 2018 Oct;66:288-293. doi: 10.1016/j.gaitpost.2018.09.005. Epub 2018 Sep 12.

33.

Diagnostic Criteria for Somatosensory Tinnitus: A Delphi Process and Face-to-Face Meeting to Establish Consensus.

Michiels S, Ganz Sanchez T, Oron Y, Gilles A, Haider HF, Erlandsson S, Bechter K, Vielsmeier V, Biesinger E, Nam EC, Oiticica J, de Medeiros ÍRT, Bezerra Rocha C, Langguth B, Van de Heyning P, De Hertogh W, Hall DA.

Trends Hear. 2018 Jan-Dec;22:2331216518796403. doi: 10.1177/2331216518796403.

34.

Scalable Nanogap Sensors for Non-Redox Enzyme Assays.

Su X, Tayebi N, Credo GM, Wu K, Elibol OH, Liu DJ, Daniels JS, Li H, Hall DA, Varma M.

ACS Sens. 2018 Sep 28;3(9):1773-1781. doi: 10.1021/acssensors.8b00500. Epub 2018 Sep 11.

PMID:
30156096
35.

Clinical detection of Hepatitis C viral infection by yeast-secreted HCV-core:Gold-binding-peptide.

Venkatesh AG, Brickner H, Looney D, Hall DA, Aronoff-Spencer E.

Biosens Bioelectron. 2018 Nov 15;119:230-236. doi: 10.1016/j.bios.2018.07.026. Epub 2018 Aug 22.

PMID:
30144754
36.

ASFMR1 splice variant: A predictor of fragile X-associated tremor/ataxia syndrome.

Vittal P, Pandya S, Sharp K, Berry-Kravis E, Zhou L, Ouyang B, Jackson J, Hall DA.

Neurol Genet. 2018 Jul 27;4(4):e246. doi: 10.1212/NXG.0000000000000246. eCollection 2018 Aug.

37.

Recruiting and retaining participants in e-Delphi surveys for core outcome set development: Evaluating the COMiT'ID study.

Hall DA, Smith H, Heffernan E, Fackrell K; Core Outcome Measures in Tinnitus International Delphi (COMiT’ID) Research Steering Group.

PLoS One. 2018 Jul 30;13(7):e0201378. doi: 10.1371/journal.pone.0201378. eCollection 2018.

38.

Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans.

Kelley KD, Checkoway H, Hall DA, Reich SG, Cunningham C, Litvan I.

Front Neurol. 2018 Jun 20;9:474. doi: 10.3389/fneur.2018.00474. eCollection 2018.

39.

Fragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future.

Hall DA, Hagerman RJ.

Front Genet. 2018 Jun 7;9:100. doi: 10.3389/fgene.2018.00100. eCollection 2018. No abstract available.

40.

Acute Stroke in Middle Cerebellar Peduncle in a Patient With FXTAS.

Hall DA, Fraint A, Dafer R.

Front Genet. 2018 May 25;9:187. doi: 10.3389/fgene.2018.00187. eCollection 2018.

41.

A narrative synthesis of research evidence for tinnitus-related complaints as reported by patients and their significant others.

Hall DA, Fackrell K, Li AB, Thavayogan R, Smith S, Kennedy V, Tinoco C, Rodrigues ED, Campelo P, Martins TD, Lourenço VM, Ribeiro D, Haider HF.

Health Qual Life Outcomes. 2018 Apr 11;16(1):61. doi: 10.1186/s12955-018-0888-9. Review.

42.

The state of clinical research in neurology.

Hall DA, Ramos AR, Gelfand JM, Videnovic A, Benatar M, Cahill C, Kluger BM, Goldman M.

Neurology. 2018 Apr 10;90(15):e1347-e1354. doi: 10.1212/WNL.0000000000005295. Epub 2018 Mar 16.

43.

The Physiological Bases of Hidden Noise-Induced Hearing Loss: Protocol for a Functional Neuroimaging Study.

Dewey RS, Hall DA, Guest H, Prendergast G, Plack CJ, Francis ST.

JMIR Res Protoc. 2018 Mar 9;7(3):e79. doi: 10.2196/resprot.9095.

44.

Defining and evaluating novel procedures for involving patients in Core Outcome Set research: creating a meaningful long list of candidate outcome domains.

Smith H, Horobin A, Fackrell K, Colley V, Thacker B, Hall DA; Core Outcome Measures in Tinnitus (COMiT) initiative.

Res Involv Engagem. 2018 Mar 2;4:8. doi: 10.1186/s40900-018-0091-5. eCollection 2018.

45.

A method for the quantification of biased signalling at constitutively active receptors.

Hall DA, Giraldo J.

Br J Pharmacol. 2018 Jun;175(11):2046-2062. doi: 10.1111/bph.14190. Epub 2018 Apr 25.

46.

Interpreting the Tinnitus Questionnaire (German version): what individual differences are clinically important?

Hall DA, Mehta RL, Argstatter H.

Int J Audiol. 2018 Jul;57(7):553-557. doi: 10.1080/14992027.2018.1442591. Epub 2018 Feb 28.

PMID:
29490515
48.

Innovations in Doctoral Training and Research on Tinnitus: The European School on Interdisciplinary Tinnitus Research (ESIT) Perspective.

Schlee W, Hall DA, Canlon B, Cima RFF, de Kleine E, Hauck F, Huber A, Gallus S, Kleinjung T, Kypraios T, Langguth B, Lopez-Escamez JA, Lugo A, Meyer M, Mielczarek M, Norena A, Pfiffner F, Pryss RC, Reichert M, Requena T, Schecklmann M, van Dijk P, van de Heyning P, Weisz N, Cederroth CR.

Front Aging Neurosci. 2018 Jan 12;9:447. doi: 10.3389/fnagi.2017.00447. eCollection 2017.

49.

Recruiting ENT and Audiology patients into pharmaceutical trials: evaluating the multi-centre experience in the UK and USA.

Sanchez VA, Hall DA, Millar B, Escabi CD, Sharman A, Watson J, Thasma S, Harris P.

Int J Audiol. 2018 Sep;57(sup4):S55-S66. doi: 10.1080/14992027.2018.1425002. Epub 2018 Jan 21.

PMID:
29355055
50.

Fragile X syndrome and fragile X-associated tremor ataxia syndrome.

Hall DA, Berry-Kravis E.

Handb Clin Neurol. 2018;147:377-391. doi: 10.1016/B978-0-444-63233-3.00025-7. Review.

PMID:
29325626

Supplemental Content

Support Center